Skip to main content
. 2010 Oct-Dec;2(4):424–427. doi: 10.4103/0975-1483.71624

Table 2.

Percentage blood glucose reduction with glibenclamide in healthy albino rats before and after esomeprazole

Esomeprazole (1.8 mg/kg) + glibenclamide (40 µg /kg)
Esomeprazole (3.6 mg/kg) + glibenclamide (40 µg /kg)
Esomeprazole (30 mg/kg) + glibenclamide (40 µg /kg)
Before esomeprazole (mean±SEM) After esomeprazole (mean±SEM) Before esomeprazole (mean±SEM) After esomeprazole (mean±SEM) Before esomeprazole (mean±SEM) After esomeprazole (mean±SEM)
Fasting - - - - - -
0.5 28.96±3.78 13.58 ± 2.35** 21.75±2.53 17.36± 5.41 16.36±1.72 42.91±1.04***
1.0 44.91±4.02 23.35 ± 2.19*** 29.11 ± 3.90 25.71±4.87 38.80±8.81 64.16±0.85**
2.0 52.05±5.59 31.26 ± 2.66** 42.71 ± 3.30 36.16±2.80 42.43±9.72 70.52±0.52**
4.0 60.49±3.65 43.39 ± 1.39*** 55.20 ± 1.97 47.56±3.55* 57.51±3.00
6.0 70.17±2.09 53.32 ± 2.01*** 60.11 ± 1.09 52.69±1.76** 64.97±1.42 72.05±4.93
8.0 58.07±3.55 66.72 ± 1.06* 69.14±2.40 58.49±4.41* 58.66±3.21 65.79±1.84*
12.0 40.77±4.72 57.80 ± 3.57** 68.29 ± 3.80 67.25±2.51 58.38±3.93 56.60±3.86
18.0 33.85±4.02 44.39±3.45* 52.06±2.94 60.60±4.59 50.92±2.79 51.86±1.40
24.0 27.98±5.90 33.61±3.62 44.64±4.59 49.29±5.16 45.68±1.16
30.0 25.07±5.95 29.77±3.03 35.18±2.99 38.62±5.40 45.05±2.78 68.68±1.44***
36.0 31.33±9.53 21.73±3.05 29.84±4.92 29.97±3.73 38.35±3.65 58.63±2.91***
42.0 20.93±4.57 16.68±2.58 16.87±3.73 20.70±2.46 37.04±1.28 55.02±1.75***
48.0 13.62±3.39 8.54±3.20 11.06±2.35 8.49±2.19 32.34±2.56 46.74±1.20***
*

Significant at P<0.05;

**

Highly significant at P<0.01;

***

Very highly significant at P<0.001